amiloride has been researched along with Proteinuria in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Antignac, C; Birn, H; Bistrup, C; Friis, UG; Hinrichs, GR; Jensen, BL; Lund, IK; Mollet, G; Nielsen, R; Svenningsen, P; Weyer, K | 1 |
| Anandakrishnan, N; Azeloglu, EU; Bagiella, E; Campbell, KN; Chauhan, K; Coca, SG; Egerman, MA; Li, H; Meliambro, K; Mosoyan, G; Raij, L; Reyes-Bahamonde, J; Runxia, T; Salem, F; Wong, JS; Wong, NJ | 1 |
| Alshehri, M; Desale, S; Shen, W; Wilcox, C | 1 |
| Ray, EC | 1 |
| He, C; Ma, J; Shi, W; Xie, S; Yang, Y; Zhang, B | 1 |
| Chi, N; Shi, W; Xu, LB | 1 |
| Rondon-Berrios, H | 1 |
| Shi, W; Xie, S; Yang, Y; Zhang, B | 1 |
| Chander, PN; Levine, S; Oruene, A; Rosenfeld, L; Sepehrdad, R; Stier, CT | 1 |
| Chander, PN; Sepehrdad, R; Singh, G; Stier, CT | 1 |
| Anestis, DK; Brown, PI; Hong, SK; Rankin, GO; Skaggs, C | 1 |
| Barbe, P; Barthe, P; Chap, H; Louvet, JP; Salles, JP | 1 |
1 review(s) available for amiloride and Proteinuria
| Article | Year |
|---|---|
[New insights into the pathophysiology of oedema in nephrotic syndrome].
Topics: Amiloride; Animals; Diet, Sodium-Restricted; Disease Models, Animal; Dogs; Edema; Epithelial Sodium Channel Blockers; Epithelial Sodium Channels; Humans; Hypoalbuminemia; Kidney Glomerulus; Kidney Tubules, Collecting; Natriuresis; Nephrotic Syndrome; Proteinuria; Rats; Rats, Mutant Strains; Serine Proteases; Sodium; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase | 2011 |
1 trial(s) available for amiloride and Proteinuria
| Article | Year |
|---|---|
The Effect of Amiloride on Proteinuria in Patients with Proteinuric Kidney Disease.
Topics: Adult; Aged; Amiloride; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Disease Progression; Drug Therapy, Combination; Epithelial Sodium Channel Blockers; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Treatment Outcome; Triamterene | 2021 |
10 other study(ies) available for amiloride and Proteinuria
| Article | Year |
|---|---|
Urokinase-type plasminogen activator contributes to amiloride-sensitive sodium retention in nephrotic range glomerular proteinuria in mice.
Topics: Amiloride; Animals; Epithelial Sodium Channel Blockers; Gene Expression Regulation; Intracellular Signaling Peptides and Proteins; Kidney Glomerulus; Membrane Proteins; Mice; Mice, Knockout; Nephrotic Syndrome; Peptide Hydrolases; Plasminogen; Proteinuria; Sodium; Urokinase-Type Plasminogen Activator; Water; Weight Loss | 2019 |
Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease.
Topics: Amiloride; Animals; Biomarkers; Edema; Glomerulosclerosis, Focal Segmental; Humans; Kidney Diseases; Kidney Glomerulus; Male; Oxidative Stress; Plasminogen; Podocytes; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Renal Insufficiency | 2020 |
ENaC blockade in proteinuria-associated extracellular fluid volume overload - effective but risky.
Topics: Amiloride; Edema; Extracellular Fluid; Humans; Hypertension; Nephrotic Syndrome; Proteinuria | 2018 |
[Amiloride reduces proteinuria and inhibits podocyte uPAR in the 5/6 nephrectomy rats].
Topics: Amiloride; Animals; Cell Movement; Disease Models, Animal; Nephrectomy; Podocytes; Proteinuria; Rats; Real-Time Polymerase Chain Reaction; Receptors, Urokinase Plasminogen Activator | 2014 |
Amiloride, a urokinase-type plasminogen activator receptor (uTPA) inhibitor, reduces proteinurea in podocytes.
Topics: Amiloride; Animals; Cell Line, Transformed; Cell Movement; Disease Models, Animal; Gene Expression; Mice; Podocytes; Proteinuria; Receptors, Urokinase Plasminogen Activator | 2015 |
Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria.
Topics: Amiloride; Animals; Cell Movement; Cells, Cultured; Disease Models, Animal; Epithelial Sodium Channels; Glomerulosclerosis, Focal Segmental; In Vitro Techniques; Integrin beta3; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Nephrectomy; Podocytes; Proteinuria; Rats; Receptors, Urokinase Plasminogen Activator; Sodium Channel Blockers; Triamterene | 2012 |
Amiloride reduces stroke and renalinjury in stroke-prone hypertensive rats.
Topics: Amiloride; Animals; Blood Pressure; Body Weight; Brain; Diuretics; Dose-Response Relationship, Drug; Genetic Predisposition to Disease; Hypertension; Kidney; Kidney Diseases; Male; Organ Size; Proteinuria; Rats; Rats, Inbred SHR; Stroke; Survival Analysis | 2003 |
Sodium transport antagonism reduces thrombotic microangiopathy in stroke-prone spontaneously hypertensive rats.
Topics: Aging; Amiloride; Animals; Biological Transport, Active; Body Weight; Diuretics; Kidney; Kidney Diseases; Male; Peripheral Vascular Diseases; Potassium; Proteinuria; Rats; Rats, Inbred SHR; Renal Circulation; Sodium; Survival Analysis; Thrombosis | 2004 |
The role of glucuronidation in N-(3,5-dichlorophenyl)succinimide (NDPS) nephrotoxicity: nephrotoxic potential of NDPS and NDPS metabolites in Gunn, Wistar, and Fischer 344 rats.
Topics: Amiloride; Animals; Blood Urea Nitrogen; Diuretics; Glucuronates; Kidney Diseases; Male; Organ Size; Proteinuria; Rats; Rats, Gunn; Rats, Inbred F344; Rats, Wistar; Serotonin; Time Factors | 1999 |
Increased platelet sodium-proton exchange rates in insulin-dependent (type 1) diabetic patients with nephropathy and hypertension.
Topics: Adolescent; Adult; Amiloride; Blood Platelets; Carrier Proteins; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Hypertension; Hypertension, Renal; Male; Middle Aged; Proteinuria; Sodium; Sodium-Hydrogen Exchangers | 1992 |